Long-term Clinical and Functional Results of Neovascular Glaucoma Surgical Treatment with Glautex Drainage and Ahmed Valve
https://doi.org/10.18008/1816-5095-2017-1-47-52
Abstract
Purpose — to determine the effect of fistulizing operations with Glautex drainage and Ahmed valve implantation in the cases with neovascular glaucoma within 3 years.
Patients and methods. We observed 44 patients (44 eyes) with secondary neovascular glaucoma on the background of post-thrombotic and proliferative diabetic retinopathy. Patient age averaged 60,84±1,29 years. Males — 19, females — 25. The patients were divided into two groups depending on the used drainages and drainage devices. In Group I the standard sinus trabeculectomy with Glautex drainage was performed in 23 patients. The II group included 21 patients who were implanted Ahmed valve.
Results. According to the results of our research the relative hypotensive effect was in groups I and II, respectively, 52.2% (12/23) and 79.4% (17/21) 1 year after surgery; 43.5% (10/23) and 71.4% (15/21) — 2 years after surgery; 39.1% (9/23) and 66.7% (14/21) — after 3 years of follow up. The maximum decrease in IOP was observed immediately after surgery in the analyzed groups, 66.8% and 64.5%, respectively. There was no surgical treatment effect for 3 years in Group I in 60.8% (14/23), in group II — 33.3% (7/21) of the cases.
Conclusion. The analysis of clinical and functional results of surgical treatment of patients with neovascular glaucoma in terms of 3 years follow up showed that the most lasting preservation of visual function and the hypotensive effect was achieved after implantation of the Ahmed valve — in 66.7% of the cases. In the cases of sinus trabeculectomy with Glautex drainage — in 39.1% of the cases. The incidence of postoperative complications in both groups was comparable: as hyphema, hypotension, and the eruption of implants developed after sinus trabeculectomy with Glautex drainage in 26.1%, 21.7% and 4.3%, respectively, after Ahmed valve implantation in 23 8%, 19.1% and 9.6% of the cases.
About the Authors
M. M. Bikbov
Ufa Eye Research Institute of Academy of Sciences of the Republic of Bashkortostan
Russian Federation
Russian Federation
MD, prof., Head of Ufa Eye Research Institute,
Pushkina str., 90, Ufa, Republic of Bashkortostan, 450008
I. I. Khusnitdinov
Ufa Eye Research Institute of Academy of Sciences of the Republic of Bashkortostan
Russian Federation
Russian Federation
PhD, Head of the II Microsurgical Department Ufa Eye Research Institute,
Pushkina str., 90, Ufa, Republic of Bashkortostan, 450008
References
1. Bessmertnyy A.M., Chervyakov A.Yu. [The use of implants in treatment of refractory glaucoma]. Primenenie implantatov v lechenii refrakternoy glaukomy. [Glaukoma]. Glaukoma. 2001;1:44-41. (In Russ.).
2. Bettin P., Di Matteo F. Glaucoma: present challenges and future trends. Ophthalmic Res. 2013;50(4):197-208. DOI: 10.1159/000348736.
3. Gheith M.E., Mayer J.R., Siam G.A. et al. Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%). Clin. Ophthalmol. 2008;2(1):15-20.
4. Horsley MB, Kahook MY. Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol. 2010;21(2):112-117. DOI: 10.1097/ICU.0b013e3283360aad.
5. Sivak-Callcott JA, O’Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001;108(10):1767-1776; quiz1777, 1800.
6. Shen C.C., Salim S., Du H., Netland P.A. Trabeculotomy versus Ahmed Glaucoma Valve implantation in neovascularglaucoma. Clin Ophthalmol. 2011;5:281-286. DOI: 10.5005/jp-journals-10008-1203
7. Avanesova T.A., Gur'eva N.V., Zhavoronkov S.A., Oleynik A.I., Egorov E.A. [Experience of Ahmed valve drainage usage in surgical treatment of refractory glaucoma]. Opyt primeneniya drenazhey Ahmed v khirurgicheskom lechenii refrakternoy glaukomy. [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2010;2:55-58. (In Russ.).
8. Bikbov M.M., Surkova V.K., Khusnitdinov I.I., Chayka O.V., Orenburkina O.I., Dzhamantaeva Sh.D. [Results of implantation of drenaige system Ahmed in patients with refractory glaucoma]. Rezul'taty primeneniya drenazha Ahmed pri refrakternoy glaukome. [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2013;3:98-101. (in Russ.).
9. Budenz D, Barton K, Feuer W, Schiffman J, Costa V, Godfrey D, Buys YM. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology. 2011;118:443–452. DOI: 10.1016/j.ophtha.2010.07.016.
10. Bikbov M.M., Surkova V.K., Khusnitdinov I.I., Orenburkina O.I., Chayka O.V. [The outcomes of refractory glaucoma surgery using collagen bio-implant]. Rezul'taty khirurgicheskogo lecheniya refrakternoy glaukomy s ispol'zovaniem kollagenovogo biodrenazha. [Ophthalmology in Russia]. Oftal'mologiya. 2014;11(2):55-58. (in Russ.). DOI: http://dx.doi.org/10.18008/1816-5095-2014-2-55-58
11. Lima F, Magacho L, Carvalho D, Susanna R, Avila M. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma. 2004;13:233–237.
12. Prokof 'eva M.I. [Modern surgical approaches to refractory glaucoma treatment. (Literary revive)]. Sovremennye khirurgicheskie podkhody k lecheniyu refrakternoy glaukomy (obzor literatury). [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2010;11(3):104-108. (in Russ.).
13. Coleman A, Hill R, Wilson M. et al. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1995;120:23–31.
14. Slonimskiy A.Yu., Alekseev I.B., Dolgiy S.S., Korigodskiy A.R. [New biodegradable drainage “Glautex” in the surgical treatment of glaucoma]. Novyy biodegradiruemyy drenazh «Glauteks» v khirurgicheskom lechenii glaukomy. [National Journal glaucoma]. Natsional'nyy zhurnal glaukoma. 2012;4:55-59. (in Russ.).
15. Papadaki T, Zacharopoulos I, Pasquale L, Christen W, Netland P, Foster CS. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144:62-69. DOI:10.1016/j.ajo.2007.03.013
16. Souza C, Tran DH, Loman J, et al. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol. 2007;144:893-900. DOI:10.1016/j.ajo.2007.07.035
17. Zhang H, Yang Y, Xu Y, Yang R, Wang B, Hu J. Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma. Int J Ophthalmol. 2014 Oct 18;7(5):837-842. DOI: 10.3980/j.issn.22223959.2014.05.18. eCollection 2014.
18. Zhou M, Wang W, Huang W, Chen S, Li X, Gao X, Zhang X. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin Med J (Engl). 2013;126(8):1412-1417.
19. Eid T, Radwan A, El-Manawy W, El-Hawary I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol. 2009;44(4):451–456. DOI: 10.3129/i09-108.
20. Sahyoun M, Azar G, Khoueir Z, Antoun J, Kourie H, Nehme J, Jalkh A. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma. J Glaucoma. 2015; 24(5):383-388. DOI: 10.1097/IJG.0000000000000234.
Review
For citations:
Bikbov M.M., Khusnitdinov I.I. Long-term Clinical and Functional Results of Neovascular Glaucoma Surgical Treatment with Glautex Drainage and Ahmed Valve. Ophthalmology in Russia. 2017;14(1):47-52. (In Russ.) https://doi.org/10.18008/1816-5095-2017-1-47-52
Views:
4454
Email this article 